Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

You need the best health care providers to ensure a proper hormone balance. Here are the top endocrinologists on.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.